MyPatientPal: An App to Help Patients Manage Their Cancer Care

NCT03684005 | Completed

• 1 other identifier: 2018-063
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

MyPatientPal was developed in collaboration with both patient and oncologist stakeholders, is designed to facilitate such patient self-management through the daily reporting of side effects and medications.

Conditions

Cancer

Outcome Measures

Primary Outcomes (1)

• Treatment-related symptoms

  The frequency of treatment-related symptoms will be examined as the primary outcome. Patients will report the frequency and severity of symptoms selected from a symptom survey that consists of a list of 17 symptoms derived from the National Cancer Institute (NCI) CTCAE (Common Terminology Criteria for Adverse Events). Examples include diarrhea, constipation, vomiting, fever, and fatigue. Patients will be asked to mark the frequency of each symptom using a 5-point rating scale (from 0=none to 4=very severe). A total symptom impact score will be calculated by summing item responses across all symptoms. The investigators will compare the overall mean difference between the weekly and daily reporting phases.

  Symptoms will be reported weekly via the internet for weeks 1-4 and daily for weeks 5-8 via the smartphone app

Secondary Outcomes (2)

• Adherence to medications

  Adherence will be reported weekly via the internet for weeks 1-4 and daily for weeks 5-8 via the smartphone app

• Patient self-efficacy

  Patient self-efficacy will be reported weekly via the internet for weeks 1-4 and daily for weeks 5-8 via the smartphone app

Study Arms (1)

Single-Arm Smartphone App Use

OTHER

All patients in this single-arm study will use a smartphone-based app, MyPatientPal, to enter symptoms and track medications related to their cancer treatment. No drugs will be administered for the purposes of this behavioral study.

Other: MyPatientPal smartphone app

Interventions

MyPatientPal smartphone app OTHER

All patients in this single-arm study will use a smartphone-based app, MyPatientPal, to enter symptoms and track medications related to their cancer treatment. No drugs will be administered for the purposes of this behavioral study.

Single-Arm Smartphone App Use

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Have a diagnosis of any solid tumor cancer
• Be starting treatment using an oral cancer therapeutic agent
• Be able to speak, read, and write English
• Willing and able to use their smartphone to use MyPatientPal

You may not qualify if:

• Patients with cognitive or perceptual disturbances

Sponsors & Collaborators

• Felicity Harper: lead

Study Sites (1)

Barbara Ann Karmanos Cancer Institute

Detroit, Michigan, 48201, United States

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

• Felicity Harper, PhD

  Associate Professor/PI

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: September 22, 2018
• First Posted: September 25, 2018
• Study Start: October 1, 2018
• Primary Completion: October 8, 2019
• Study Completion: October 11, 2019
• Last Updated: March 2, 2021

Record last verified: 2021-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)